Search the Newsreel

Is Herbalife’s Mixed Q2 Results and CFO Exit Altering The Investment Case For Herbalife (HLF)?

Outlook Therapeutics (OTLK) CFO Lawrence Kenyon buys 101K shares plus 101K warrants

Outlook Therapeutics' CFO, Lawrence A. Kenyon, purchased 101,010 shares of common stock and 101,010 accompanying warrants in an underwritten public offering on August 14, 2026. The combined offering price was $0.99 per share and warrant, with the warrants immediately exercisable at $1.10 and expiring …

Protagonist Therapeutics (NASDAQ:PTGX) Screens as an Affordable Growth Opportunity

Theravance Biopharma Deal Faces Investor Probe

Halper Sadeh LLC is investigating the proposed acquisition of Theravance Biopharma (NASDAQ: TBPH) by Zymeworks Inc. for $17 per share in cash plus a contingent value right. The investigation aims to determine if Theravance shareholders are receiving a fair price and if the company's …

XORTX Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock

Edgewise Therapeutics CEO Kevin Koch sold $785,042 worth of company stock on August 12, 2026, primarily to cover tax obligations related to Restricted Stock Unit vesting. Despite the sales, Mr. Koch also acquired new shares through vesting and was granted additional RSUs and stock …

Walleye Capital LLC Takes $1.59 Million Position in PTC Therapeutics, Inc. $PTCT

Walleye Capital LLC has acquired a new position in PTC Therapeutics, Inc., purchasing 19,522 shares valued at approximately $1.59 million during the second quarter. Several other institutional investors also increased their holdings in the biopharmaceutical company, which has an average analyst rating of "Moderate …

Weekly Recap: Sherwin-Williams & Valspar Paint Top This Week’s Stories

This article provides a weekly recap of the most-viewed news stories on Coatings World, highlighting key developments in the paint and coatings industry for the week ending August 15, 2026. Top stories include Sherwin-Williams' new ControlTech systems, Valspar Paint's Ready-Mix collection, and an interview …

LENZ Therapeutics (NASDAQ:LENZ) Stock Rating Upgraded by Zacks Research

Walleye Capital LLC Purchases New Shares in Kyverna Therapeutics, Inc. $KYTX

Walleye Capital LLC Purchases New Stake in Aquestive Therapeutics, Inc. $AQST

Walleye Capital LLC has acquired a new stake of 282,568 shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST), valued at approximately $1.18 million. Institutional investors collectively hold 32.45% of the company's stock, while insider ownership stands at 6.81%. Despite a wider-than-expected quarterly loss, analysts maintain a …

TBPH Stock Alert: Halper Sadeh LLC is Investigating Whether Theravance Biopharma, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Theravance Biopharma, Inc. (NASDAQ: TBPH) to Zymeworks Inc. for $17.00 per share. The investigation focuses on whether Theravance's board failed to secure the best possible price, conducted a fair sales process, …

Plan Group Financial LLC Invests $3.59 Million in Southern Company (The) $SO

Plan Group Financial LLC recently invested $3.59 million in Southern Company, acquiring 37,485 shares. Other institutional investors also adjusted their holdings, with a total of 64.1% of the stock owned by hedge funds and institutions. Southern Company reported better-than-expected EPS but slightly missed revenue …

Mineralys Therapeutics (NASDAQ:MLYS) Downgraded by Zacks Research to "Strong Sell"

Zacks Research downgraded Mineralys Therapeutics (NASDAQ:MLYS) to a "Strong Sell" rating, despite a mixed analyst sentiment with an average "Hold" rating and a $49.33 price target. The downgrade follows a significant earnings miss, with the company reporting a quarterly loss of $2.85 per share …

Zacks Research Downgrades Monopar Therapeutics (NASDAQ:MNPR) to Hold

Zacks Research downgraded Monopar Therapeutics (NASDAQ:MNPR) from a "strong-buy" to a "hold" rating, despite the broader analyst consensus remaining a "moderate buy" with an average price target of $117.42. The company's shares opened at $113.04, trading near their 12-month high, and it recently reported …

Electrotherm Publishes Q1 FY27 Unaudited Results in Financial Express

Walleye Capital LLC Purchases Shares of 102,163 Rapport Therapeutics, Inc. $RAPP

Walleye Capital LLC has acquired a new position in Rapport Therapeutics, purchasing 102,163 shares valued at $4.26 million, representing 0.21% of the company. Despite the stock opening near its 52-week high, Rapport Therapeutics reported a quarterly loss of $1.19 per share, missing estimates. Analysts …

Walleye Capital LLC Acquires Shares of 179,992 Southern First Bancshares, Inc. $SFST

Walleye Capital LLC has acquired 179,992 shares of Southern First Bancshares, Inc. (NASDAQ:SFST) in the second quarter, valued at approximately $11.0 million, representing about 1.9% of the company. Institutional investors now collectively own 75% of SFST. Analysts maintain a positive outlook with a consensus …

128,006 Shares in Maze Therapeutics, Inc. $MAZE Acquired by Walleye Capital LLC

Walleye Capital LLC has acquired 128,006 shares of Maze Therapeutics, Inc. (NASDAQ:MAZE) during the second quarter, a position valued at approximately $3.82 million. Despite this acquisition and a consensus "Buy" rating from analysts with an average price target of $66, the company reported a …

Walleye Capital LLC Invests $6.80 Million in Allogene Therapeutics, Inc. $ALLO

Walleye Capital LLC has invested $6.80 million in Allogene Therapeutics, acquiring 3.27 million shares, representing approximately 0.95% of the company. Other institutional investors have also adjusted their stakes, with a significant 83.63% of the stock owned by institutional investors and hedge funds. Allogene Therapeutics …

Walleye Capital LLC Purchases Shares of 241,987 Trevi Therapeutics, Inc. $TRVI

Walleye Capital LLC has acquired a new stake of 241,987 shares in Trevi Therapeutics, Inc. (NASDAQ:TRVI) during the second quarter, valued at approximately $4.5 million. This investment contributes to the 95.76% institutional ownership of the company. Trevi Therapeutics maintains a "Buy" consensus rating from …

Oppenheimer Asset Management Inc. Invests $7.82 Million in Southern Copper Corporation $SCCO

Oppenheimer Asset Management Inc. has invested $7.82 million in Southern Copper Corporation (SCCO) by purchasing 44,885 shares. Other institutional investors have also recently adjusted their holdings in the company. Southern Copper reported strong quarterly earnings, beating estimates, and increased its quarterly dividend, though analysts …

How (ADXN) Movements Inform Risk Allocation Models

This article analyzes Addex Therapeutics Ltd (NASDAQ: ADXN), highlighting a positive near-term sentiment but broader weak alignment. It presents an exceptional 60.0:1 risk-reward setup targeting a 20.6% gain against a 0.3% risk. The article outlines institutional trading strategies, including position trading, momentum breakout, and …

Assetmark Inc. Trims Stock Holdings in Toll Brothers Inc. $TOL

Assetmark Inc. reduced its stake in Toll Brothers Inc. by 6% in the second quarter, selling 11,495 shares but still holding 179,605 shares valued at approximately $29.6 million. Despite insider selling by COO Robert Parahus and Chairman Douglas C. Yearley, other institutional investors significantly …

Citizens & Northern (NASDAQ:CZNC) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded Citizens & Northern (NASDAQ:CZNC) to a "strong-buy" rating. This follows other upgrades from Weiss Ratings and Zacks Research, although the overall analyst consensus remains "Hold" with a $23.50 target price. The company recently reported strong quarterly earnings of $0.79 per …

MGO One Seven LLC Sells 7,698 Shares of Toll Brothers Inc. $TOL

MGO One Seven LLC significantly reduced its stake in Toll Brothers Inc. (NYSE:TOL) by selling 7,698 shares, cutting its holdings by 70.4%. Despite this, Toll Brothers surpassed quarterly earnings expectations with an EPS of $2.72 and revenue of $2.53 billion, even as revenue declined …

Milford Funds Ltd. Sells 19,252 Shares of Toll Brothers Inc. $TOL

Milford Funds Ltd. has reduced its stake in Toll Brothers Inc. (NYSE:TOL) by selling 19,252 shares, retaining 335,735 shares valued at approximately $55.3 million. This comes as institutional investors collectively own 91.76% of the company, and several company executives, including COO Robert Parahus and …

C4 Therapeutics (CCCC) gains 6.9% disclosed stake from Squadron Master Fund

Squadron Master Fund LP and related entities have disclosed a 6.9% beneficial ownership stake in C4 Therapeutics (CCCC), totaling 7,600,000 shares. This includes 7,200,000 common shares and 400,000 shares underlying currently exercisable long call options. The filing indicates shared voting and dispositive powers among …

Welch Group LLC Buys 4,089 Shares of The Sherwin-Williams Company $SHW

Welch Group LLC increased its stake in The Sherwin-Williams Company (NYSE:SHW) by 15.2% in the second quarter, bringing its total holdings to 30,991 shares valued at $10.67 million. Other institutional investors also adjusted their positions in Sherwin-Williams, which maintains a "Moderate Buy" consensus rating …

Dockside LLC Takes $2.84 Million Position in Southern Company (The) $SO

Dockside LLC recently acquired 29,642 shares of Southern Company, valued at approximately $2.84 million, establishing a new position in the utility provider. This move is part of broader institutional investor activity, with entities like Norges Bank and Capital World Investors also making significant investments …

Value Partners Investments Inc. Reduces Holdings in Thermo Fisher Scientific Inc. $TMO

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

Archer Aviation Has $6.9 Million of Revenue. It's Buying a Boeing Business With More Than $200 Million.

Archer Aviation (NYSE: ACHR) is buying Boeing's (NYSE: BA) Wisk Aero, Insitu, and SkyGrid subsidiaries, and the price is a piece of itself. At closing, Archer will issue Boeing new stock equal to 19.75% of its shares outstanding just before the deal completes -- …

Protara Therapeutics (NASDAQ:TARA) Downgraded to Strong Sell Rating by Wall Street Zen

Wall Street Zen has downgraded Protara Therapeutics (NASDAQ:TARA) from a "sell" to a "strong sell" rating, despite a broader analyst consensus of "Moderate Buy" with an average price target of $26.25. The company's shares were trading at $3.97, near their 52-week low, after reporting …

Wedge Capital Management L L P NC Buys Shares of 128,845 Theravance Biopharma, Inc. $TBPH

Wedge Capital Management L L P NC recently acquired 128,845 shares of Theravance Biopharma (NASDAQ:TBPH) worth approximately $2.19 million, now owning about 0.25% of the company. Institutional investors hold 99.10% of TBPH, despite the company reporting an adjusted loss and missing revenue expectations in …

Security National Bank Boosts Stock Position in Thermo Fisher Scientific Inc. $TMO

Security National Bank increased its stake in Thermo Fisher Scientific Inc. (TMO) by 18.5% in the second quarter, bringing its total holdings to 14,095 shares valued at approximately $7.1 million. The article also notes that institutional investors own 89.23% of TMO, and analysts generally …